PELLICCIARI ROBERTO has a total of 37 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1990. It filed its patents most often in United States, Italy and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are NEURMEDIX INC, TELOMERASE ACTIVATION SCIENCES INC and REVERAGEN BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | Italy | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Canada | 2 | |
#6 | Hong Kong | 2 | |
#7 | Australia | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Pellicciari Roberto | 37 |
#2 | Moroni Flavio | 19 |
#3 | Gilbert Adam Matthew | 5 |
#4 | Gilbert Adam M | 4 |
#5 | Larkin Peter John | 3 |
#6 | Schwarcz Robert | 3 |
#7 | Hansen Eric Christian | 3 |
#8 | Guidetti Paolo | 2 |
#9 | Gilbert Adam | 2 |
#10 | Stone Trevor W | 1 |
Publication | Filing date | Title |
---|---|---|
US2009325951A1 | Thienyl-and furanyl-isoquinolinones and methods for using them | |
WO2006013085A1 | 4-sulfonyl-substituted benzoylalanine derivates useful as kynurenine-aminotransferase inhibitors | |
AU2003250935A1 | Bile acid derivatives as agonists of the farnesoid x receptor | |
WO02072598A1 | Steroids as agonists for fxr | |
ITMI922216D0 | Nitrobenzoyl alanines, process for their preparation, their use as therapeutic agents and pharmaceutical compositions containing them | |
WO9117750A1 | Nicotinylalanine as a therapeutic agent acting on the central nervous system |